Glyceryl trinitrate in first-episode psychosis unmedicated with antipsychotics: A randomised controlled pilot study

BACKGROUND: There is a pressing need for new classes of treatment for psychosis. A key therapeutic target for novel compounds is the NMDA receptor, which may be modulated by nitric oxide donors such as sodium nitroprusside (SNP). Recent studies of SNP in patients with psychosis have mixed results, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Merritt, Kate, Catalan, Ana, Cowley, Samuel, Demjaha, Arsime, Taylor, Matthew, McGuire, Philip, Cooper, Ruth, Morrison, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376621/
https://www.ncbi.nlm.nih.gov/pubmed/32436761
http://dx.doi.org/10.1177/0269881120922967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376621/
https://www.ncbi.nlm.nih.gov/pubmed/32436761
http://dx.doi.org/10.1177/0269881120922967

Ejemplares similares